Reuters
03 Aug 2026, 11:39 UTC · 1h ago
Curium strikes up to $8 bln deal for radiopharma peer Lantheus
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Reuters
03 Aug 2026, 11:39 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
1 claim · each scored for market impact
Curium has agreed to acquire Lantheus Holdings in a deal valued at up to $8 billion. — Large-scale M&A in the radiopharmaceutical sector indicates strong valuation benchmarks and consolidation trends, typically boosting sentiment for the target and peers.
+0.60Which stocks this story touches
Continue reading
6 related stories
Top 1 mover · tap to explore
[a_to_b] Curium has agreed to buy Lantheus Holdings in a deal worth up to $8 billion.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
2h ago
